Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-06-18

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Haloperidol decanoate, updating the product label under the Hikma Pharmaceuticals USA Inc. filing for this long-acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)